<bill session="115" type="h" number="5150" updated="2023-01-11T13:40:21Z">
  <state datetime="2018-03-01">REFERRED</state>
  <status>
    <introduced datetime="2018-03-01"/>
  </status>
  <introduced datetime="2018-03-01"/>
  <titles>
    <title type="display">Protecting Medicare from Excessive Price Increases Act of 2018</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to require drug manufacturers to pay a Medicare part B rebate for certain drugs if the price of such drugs increases faster than inflation.</title>
    <title type="short" as="introduced">Protecting Medicare from Excessive Price Increases Act of 2018</title>
  </titles>
  <sponsor bioguide_id="L000263"/>
  <cosponsors>
    <cosponsor bioguide_id="B000574" joined="2018-03-13"/>
    <cosponsor bioguide_id="C001080" joined="2018-04-18"/>
    <cosponsor bioguide_id="G000551" joined="2018-04-10"/>
    <cosponsor bioguide_id="J000032" joined="2018-03-13"/>
  </cosponsors>
  <actions>
    <action datetime="2018-03-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-03-01" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-03-01">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-03-02">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-03-09">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Manufacturing"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-09-06T22:36:48Z" status="Introduced in House">Protecting Medicare from Excessive Price Increases Act of 2018

This bill requires a drug manufacturer to pay&#160;a Medicare&#160;rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.</summary>
</bill>
